Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values

Protein Eng Des Sel. 2017 Sep 1;30(9):611-617. doi: 10.1093/protein/gzx028.

Abstract

While potent monoclonal antibodies against ricin were introduced over the years, the question whether increasing antibody affinity enables better toxin neutralization was not fully addressed yet. The aim of this study was to characterize the contribution of antibody affinity to the ricin neutralization potential of the antibody. cHD23 monoclonal antibody that targets the toxin B-subunit and interferes with its binding to membranal receptors, was isolated. In order to create antibody clones with improved affinity toward ricin, a scFv-phage display library containing mutated versions of the variable regions of cHD23 was constructed and clones with improved binding of ricin were isolated. Structural modeling of these mutants suggests that the inserted mutations may increase the antibody conformational flexibility thus improving its ability to bind ricin. While it was found that the selected clones exhibited improved neutralization of ricin, the correlation between the KD values and potency was only minor (r = 0.55). However, a positive correlation (r = 0.84) exist between the off-rate values (koff) of the affinity matured clones and their ability to neutralize ricin. As cell membranes display inordinately large amounts of potential surface binding sites for ricin, it is suggested that antibodies with improved off-rate values block the ability of the toxin to bind to target receptors, in a highly efficient manner. Currently, antibody-based therapy is the most effective treatment for ricin intoxication and it is anticipated that the findings of this study will provide useful information and a possible strategy to design an improved antibody-based therapy for the toxin.

Keywords: affinity maturation; antibodies; post-exposure therapy; ricin; toxin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis
  • Antibodies, Monoclonal / chemistry*
  • Antibodies, Monoclonal / isolation & purification
  • Antibodies, Neutralizing / biosynthesis
  • Antibodies, Neutralizing / chemistry*
  • Antibodies, Neutralizing / isolation & purification
  • Antibody Affinity*
  • Cloning, Molecular
  • HeLa Cells
  • Humans
  • Hybridomas / chemistry
  • Hybridomas / immunology
  • Kinetics
  • Mice
  • Mice, Inbred BALB C
  • Models, Molecular
  • Mutation
  • Neutralization Tests
  • Peptide Library*
  • Protein Binding
  • Protein Structure, Secondary
  • Ricin / antagonists & inhibitors*
  • Ricin / chemistry
  • Ricin / immunology
  • Single-Chain Antibodies / biosynthesis
  • Single-Chain Antibodies / chemistry*
  • Single-Chain Antibodies / isolation & purification

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Peptide Library
  • Single-Chain Antibodies
  • Ricin